-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MmGPlhdJmuOOlvraL9H9P76qhWaBOZeXGx6JpsHMcjxdQ7lhUtp5+1+u7gHDEqyA vObl1u8JqYuB0+8Khgq9+g== 0001193125-10-038304.txt : 20100224 0001193125-10-038304.hdr.sgml : 20100224 20100224090031 ACCESSION NUMBER: 0001193125-10-038304 CONFORMED SUBMISSION TYPE: 25 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100224 DATE AS OF CHANGE: 20100224 EFFECTIVENESS DATE: 20100224 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TARGETED GENETICS CORP /WA/ CENTRAL INDEX KEY: 0000921114 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911549568 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 25 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23930 FILM NUMBER: 10628312 BUSINESS ADDRESS: STREET 1: 1100 OLIVE WAY STREET 2: STE 100 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: 2066237612 MAIL ADDRESS: STREET 1: 1100 OLIVE WAY STREET 2: STE 100 CITY: SEATTLE STATE: WA ZIP: 98101 25 1 d25.htm NOTIFICATION OF REMOVAL FROM LISTING Notification of Removal From Listing

 

 

 

OMB Number:    3235-0080
Expires:    January 31, 2012

Estimated average burden

hours per response. . . 

    1.00

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR

REGISTRATION UNDER SECTION 12(b) OF THE

SECURITIES EXCHANGE ACT OF 1934.

Commission File Number:  0-23930

Issuer: Targeted Genetics Corporation

Exchange: NASDAQ Stock Market, LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

1100 Olive Way, Suite 100, Seattle, Washington 98101; (206) 623-7612

(Address, including zip code, and telephone number, including area code, of Issuer’s principal executive offices)

Common Stock, $0.01 par value

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

 

  ¨ 17 CFR 240.12d2-2(a)(1)

 

  ¨ 17 CFR 240.12d2-2(a)(2)

 

  ¨ 17 CFR 240.12d2-2(a)(3)

 

  ¨ 17 CFR 240.12d2-2(a)(4)

 

  ¨ Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.

 

  x Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements of the Securities Exchange Act of 1934, Targeted Genetics Corporation certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

 

February 24, 2010

   By  

/s/ David J. Poston

  

Vice President, Finance and

Chief Financial Officer

Date   Name:   David J. Poston   Title

 

1

Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

 

 

 

 -----END PRIVACY-ENHANCED MESSAGE-----